IL-12 receptor β2 (IL-12Rβ2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites

被引:137
作者
Wu, CY
Wang, X
Gadina, M
O'Shea, JJ
Presky, DH
Magram, J
机构
[1] Hoffmann La Roche Inc, Dept Inflammat Autoimmune Dis, Nutley, NJ 07110 USA
[2] NIAMSD, Lymphocyte Cell Biol Sect, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.165.11.6221
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Two subunits of the IL-12 receptor (IL-12R), IL-12R beta1 and IL-12R beta2, have been identified and cloned. Previous studied dem demonstrated that the IL-12R beta1 subunit was required for mouse T and NK cells to respond to IL-12 in vivo. To investigate the role of IL-12R beta2 in IL-12 signaling, we have generated IL-12R beta2-deficient (IL-12R beta2(-/-)) mice by targeted mutation in embryonic stem (ES) cells, Although Con A-activated splenocytes from IL-12R beta2(-/-) mice still bind IL-12 with both high and low affinity, no IL-12-induced biological functions can be detected, Con A-activated splenocytes of IL-12R beta2(-/-) mice failed to produce IFN-gamma or proliferate in response to IL-12 stimulation. NK lytic activity of IL-12R beta2(-/-) splenocytes was not induced when incubated with IL-12, IL-12R beta2(-/-) splenocytes were deficient in IFN-gamma secretion when stimulated with either Con A or anti-CD3 mAb in vitro, Furthermore, IL-12R beta2(-/-) mice were deficient in vivo in their ability to produce IFN-gamma following endotoxin administration and to generate a type I cytokine response, IL-12-mediated signal transduction was also defective as measured by phosphorylation of STAT4, These results demonstrate that although mouse IL-12R beta1 is the subunit primarily responsible for binding IL-12, IL-12R beta2 plays an essential role in mediating the biological functions of IL-12 in mice.
引用
收藏
页码:6221 / 6228
页数:8
相关论文
共 39 条
[1]  
ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803
[2]   Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency [J].
Altare, F ;
Durandy, A ;
Lammas, D ;
Emile, JF ;
Lamhamedi, S ;
Le Deist, F ;
Drysdale, P ;
Jouanguy, E ;
Döffinger, R ;
Bernaudin, F ;
Jeppsson, O ;
Gollob, JA ;
Meinl, E ;
Segal, AW ;
Fischer, A ;
Kumararatne, D ;
Casanova, JL .
SCIENCE, 1998, 280 (5368) :1432-1435
[3]  
CHIZZONITE R, 1992, J IMMUNOL, V148, P3117
[4]  
CHIZZONITE R, 1991, J IMMUNOL, V147, P1548
[5]  
Cho SS, 1996, J IMMUNOL, V157, P4781
[6]  
CHUA AO, 1995, J IMMUNOL, V155, P4286
[7]  
CHUA AO, 1994, J IMMUNOL, V153, P128
[8]  
de Jong R, 1998, SCIENCE, V280, P1435
[9]  
GATELY MK, 1988, J IMMUNOL, V141, P189
[10]   ADMINISTRATION OF RECOMBINANT IL-12 TO NORMAL MICE ENHANCES CYTOLYTIC LYMPHOCYTE ACTIVITY AND INDUCES PRODUCTION OF IFN-GAMMA IN-VIVO [J].
GATELY, MK ;
WARRIER, RR ;
HONASOGE, S ;
CARVAJAL, DM ;
FAHERTY, DA ;
CONNAUGHTON, SE ;
ANDERSON, TD ;
SARMIENTO, U ;
HUBBARD, BR ;
MURPHY, M .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (01) :157-167